Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2003 by National Cancer Institute (NCI). Recruitment status was Active, not recruiting
Study NCT00009750
Information provided by National Cancer Institute (NCI)
First Received on February 2, 2001.
Last Updated on February 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study: